This appeared to be consistent with previous publications demonstrating a potential tumor-promoting effect of LRG-1 on other malignancies, such as hepatocellular carcinoma [44], glioblastoma [20, 45] and colon cancer [46]. Here, LRG1 is linked to neoplasm.